Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -100.63%-24K | 4.86%3.82M | 828.32%3.64M | 87.56%392K | -9.52%209K | |||||
| Operating revenue | ---- | ---- | ---- | ---- | ---- | -100.63%-24K | 4.86%3.82M | 828.32%3.64M | 87.56%392K | -9.52%209K |
| Cost of revenue | -58.87%1.23M | 20.20%2.98M | 3,163.16%2.48M | 24.59%76K | -89.13%61K | |||||
| Gross profit | -249.70%-1.25M | -27.96%835K | 266.77%1.16M | 113.51%316K | 144.85%148K | |||||
| Operating expense | -26.46%6.45M | -17.20%8.77M | -34.78%10.59M | -10.31%16.24M | -89.51%18.11M | 658.31%172.54M | 17.63%22.75M | 42.74%19.34M | 79.67%13.55M | 29.30%7.54M |
| Selling and administrative expenses | -16.61%2.8M | -18.61%3.36M | -10.94%4.13M | -46.33%4.63M | -29.66%8.64M | -10.93%12.28M | 11.00%13.78M | 23.96%12.42M | 92.78%10.02M | 58.27%5.2M |
| -Selling and marketing expense | ---- | ---- | -55.56%20K | -64.00%45K | -73.85%125K | -53.23%478K | -25.02%1.02M | 80.29%1.36M | 38.97%756K | 37.37%544K |
| -General and administrative expense | -16.61%2.8M | -18.21%3.36M | -10.50%4.11M | -46.08%4.59M | -27.87%8.51M | -7.55%11.8M | 15.44%12.76M | 19.36%11.05M | 99.08%9.26M | 61.14%4.65M |
| Research and development costs | -78.95%12K | -82.35%57K | -34.62%323K | --494K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation amortization depletion | -24.65%162K | -32.39%215K | -19.08%318K | -48.49%393K | -45.66%763K | 69.36%1.4M | 6.15%829K | -3.94%781K | 15.48%813K | -41.28%704K |
| -Depreciation and amortization | -24.65%162K | -32.39%215K | -19.08%318K | -48.49%393K | -45.66%763K | 69.36%1.4M | 6.15%829K | -3.94%781K | 15.48%813K | -41.28%704K |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.39%2K | --326K |
| Other operating expenses | -32.39%3.47M | -11.76%5.14M | -45.67%5.82M | 23.08%10.72M | -94.52%8.71M | 1,851.35%158.86M | 32.48%8.14M | 126.00%6.15M | 106.61%2.72M | -2.59%1.32M |
| Operating profit | 26.46%-6.45M | 17.20%-8.77M | 34.78%-10.59M | 10.31%-16.24M | 89.58%-18.11M | -692.91%-173.79M | -20.53%-21.92M | -37.39%-18.18M | -79.00%-13.24M | -19.97%-7.39M |
| Net non-operating interest income (expenses) | -55.80%259K | -8.58%586K | 560.82%641K | -32.64%97K | -83.91%144K | -70.06%895K | 86.46%2.99M | 466.43%1.6M | 272.56%283K | 73.76%-164K |
| Non-operating interest income | -55.02%269K | -7.86%598K | 474.34%649K | -37.57%113K | -80.93%181K | -68.30%949K | 70.40%2.99M | 287.86%1.76M | 311.82%453K | 22.22%110K |
| Non-operating interest expense | -16.67%10K | 50.00%12K | -50.00%8K | -56.76%16K | -31.48%37K | 980.00%54K | -96.75%5K | -9.41%154K | -37.96%170K | -61.68%274K |
| Other net income (expenses) | -104.92%-16K | -60.84%325K | -0.60%830K | -4.79%835K | 103.54%877K | -2,805.46%-24.78M | 60.98%916K | -25.91%569K | -32.33%768K | 147.95%1.14M |
| Special income (charges) | ---200K | ---- | ---- | ---- | ---- | ---25.97M | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --200K | ---- | ---- | ---- | ---- | --25.88M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --96K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -43.38%184K | -60.84%325K | -0.60%830K | -4.79%835K | -26.43%877K | 35.30%1.19M | 54.56%881K | -25.68%570K | -32.42%767K | 142.00%1.14M |
| Income before tax | 21.02%-6.21M | 13.84%-7.86M | 40.42%-9.12M | 10.41%-15.31M | 91.36%-17.08M | -997.41%-197.68M | -12.50%-18.01M | -31.42%-16.01M | -89.69%-12.18M | 29.84%-6.42M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 21.02%-6.21M | 13.84%-7.86M | -12,766.67%-9.12M | 100.34%72K | 89.30%-21.15M | -997.41%-197.68M | -12.50%-18.01M | -31.42%-16.01M | -89.69%-12.18M | 21.91%-6.42M |
| Net income continuous operations | 21.02%-6.21M | 13.84%-7.86M | 40.42%-9.12M | 10.41%-15.31M | 91.36%-17.08M | -997.41%-197.68M | -12.50%-18.01M | -31.42%-16.01M | -89.69%-12.18M | 29.84%-6.42M |
| Net income discontinuous operations | ---- | ---- | ---- | 477.84%15.38M | ---4.07M | ---- | ---- | ---- | ---- | ---- |
| Noncontrolling interests | 54.12%-89K | -110.87%-194K | -92K | |||||||
| Net income attributable to the company | 21.02%-6.21M | 13.84%-7.86M | -12,766.67%-9.12M | 100.34%72K | 89.33%-21.07M | -1,001.96%-197.48M | -11.92%-17.92M | -31.42%-16.01M | -89.69%-12.18M | 21.91%-6.42M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 21.02%-6.21M | 13.84%-7.86M | -12,766.67%-9.12M | 100.34%72K | 89.33%-21.07M | -1,001.96%-197.48M | -11.92%-17.92M | -31.42%-16.01M | -89.69%-12.18M | 21.91%-6.42M |
| Diluted earnings per share | 22.22%-0.07 | 10.00%-0.09 | -12,600.00%-0.1 | 100.31%0.0008 | 90.17%-0.26 | -1,002.50%-2.646 | 6.61%-0.24 | -3.21%-0.257 | -59.62%-0.249 | 45.38%-0.156 |
| Basic earnings per share | 22.22%-0.07 | 10.00%-0.09 | -12,600.00%-0.1 | 100.31%0.0008 | 90.17%-0.26 | -1,002.50%-2.646 | 6.61%-0.24 | -3.21%-0.257 | -59.62%-0.249 | 45.38%-0.156 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |